MBE Wealth Management LLC Makes New Investment in Chemed Corporation (NYSE:CHE)

MBE Wealth Management LLC bought a new stake in Chemed Corporation (NYSE:CHE - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 543 shares of the company's stock, valued at approximately $334,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Synergy Asset Management LLC grew its holdings in shares of Chemed by 108.4% in the first quarter. Synergy Asset Management LLC now owns 3,049 shares of the company's stock valued at $1,876,000 after purchasing an additional 1,586 shares in the last quarter. Cabot Wealth Management Inc. increased its holdings in Chemed by 1.4% during the 1st quarter. Cabot Wealth Management Inc. now owns 23,750 shares of the company's stock worth $14,614,000 after purchasing an additional 329 shares during the period. Covea Finance boosted its stake in shares of Chemed by 8.3% in the 1st quarter. Covea Finance now owns 6,500 shares of the company's stock valued at $4,000,000 after buying an additional 500 shares during the period. Blue Trust Inc. grew its position in shares of Chemed by 6.5% during the first quarter. Blue Trust Inc. now owns 1,645 shares of the company's stock worth $1,012,000 after buying an additional 101 shares in the last quarter. Finally, Silver Oak Securities Incorporated purchased a new stake in shares of Chemed during the first quarter worth approximately $309,000. Hedge funds and other institutional investors own 95.85% of the company's stock.

Chemed Trading Up 0.5%

CHE stock traded up $2.49 on Monday, hitting $551.14. The company's stock had a trading volume of 79,029 shares, compared to its average volume of 104,922. Chemed Corporation has a 1 year low of $512.12 and a 1 year high of $623.61. The stock has a market cap of $8.06 billion, a price-to-earnings ratio of 26.85, a price-to-earnings-growth ratio of 2.28 and a beta of 0.54. The firm has a 50 day moving average of $566.63 and a two-hundred day moving average of $564.82.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating the consensus estimate of $5.59 by $0.04. Chemed had a return on equity of 27.58% and a net margin of 12.40%. The firm had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. During the same period in the prior year, the business earned $5.20 EPS. The firm's revenue was up 9.8% compared to the same quarter last year. As a group, equities analysts forecast that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 17th. Investors of record on Thursday, May 29th were given a $0.50 dividend. The ex-dividend date was Thursday, May 29th. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. Chemed's dividend payout ratio (DPR) is 9.74%.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,500 shares of the company's stock in a transaction on Monday, May 5th. The stock was sold at an average price of $576.45, for a total transaction of $864,675.00. Following the transaction, the chief executive officer now owns 101,197 shares of the company's stock, valued at $58,335,010.65. This represents a 1.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. In the last three months, insiders have sold 5,500 shares of company stock valued at $3,213,780. 3.29% of the stock is owned by company insiders.

Analysts Set New Price Targets

CHE has been the subject of a number of analyst reports. Royal Bank Of Canada boosted their target price on shares of Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. Wall Street Zen raised shares of Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.